Aptamer Group (LON:APTA) Reaches New 12-Month Low – Should You Sell?

Aptamer Group plc (LON:APTA – Get Free Report)’s stock price reached a new 52-week low on Thursday. The company traded as low as GBX 0.28 and last traded at GBX 0.31, with a volume of 20,131,531 shares trading hands. The stock had previously closed at GBX 0.30.

Aptamer Group Trading Up 2.3%

The company’s 50 day moving average is GBX 0.34 and its 200 day moving average is GBX 0.57. The company has a market cap of £10.65 million, a PE ratio of -2.79 and a beta of 0.87.

Aptamer Group (LON:APTA – Get Free Report) last issued its quarterly earnings results on Tuesday, October 13th. The company reported GBX (0.07) EPS for the quarter. Aptamer Group had a negative return on equity of 46.61% and a negative net margin of 120.60%.

Aptamer Group Company Profile

(Get Free Report)

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.

Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.

Further Reading

Receive News & Ratings for Aptamer Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptamer Group and related companies with MarketBeat.com's FREE daily email newsletter.